Recovery From Paranoia: a Qualitative Exploration
NCT04824781 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15
Last updated 2022-05-19
Summary
Paranoia, the experience of undue or excessive mistrust, exists on a continuum which includes suspicious thoughts, ideas of reference, and persecutory delusions. Persecutory delusions refers to strong unfounded fears that others intend harm. These fears are very common. They affect around 70% of patients with schizophrenia. They can be distressing and make day-to-day tasks difficult. However, current treatments are limited and a significant proportion of people do not benefit sufficiently. Therefore, improvements in treatment are needed. A better understanding of the experience of recovery from paranoia will help inform theoretical understanding and treatment development. Currently we do not fully understand what causes paranoia to occur, persist, or end. As such, it is critical to understand the experiences of those who have recovered, in particular what elements encourage recovery. Therefore, the aim of this study is to gain a first-person perspective on how people recover from paranoia and what psychological processes are important for recovery from paranoia. Using a qualitative approach appropriate for exploratory research, semi-structured interviews will be conducted with 12-15 patients who have recovered from paranoia. Interviews will be analysed using interpretative phenomenological analysis, a qualitative research approach which aims to provide insight on how an individual, in a particular situation, makes sense of their experience.
Conditions
- Paranoia
- Persecutory Delusion
Interventions
- OTHER
-
Qualitative interview
Participants will be interviewed about their experiences of recovery from paranoia.
Sponsors & Collaborators
-
University of Oxford
lead OTHER
Principal Investigators
-
Dr Felicity Waite, DClinPsy, BSc (Hons) · University of Oxford
Eligibility
- Min Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-06-09
- Primary Completion
- 2021-07-27
- Completion
- 2022-02-16
Countries
- United Kingdom
Study Locations
More Related Trials
-
Neural Effects of Cognitive-behaviour Therapy in Panic Disorder
NCT03251235 ·Status: COMPLETED ·Phase: NA
-
Developing Effective Response Inhibition Training for Symptom Relief in OCD and Trichotillomania
NCT02059980 ·Status: COMPLETED ·Phase: NA
-
Expectation of Unpleasant Events in Anxiety Disorders
NCT00055224 ·Status: COMPLETED ·Phase: NA
-
Relationship Obsessive Beliefs and Thought Control
NCT05791578 ·Status: UNKNOWN
-
Computerised Interventions for Thinking and Anxiety in Delusions (CITADEL) Trial
NCT01920685 ·Status: COMPLETED ·Phase: NA
-
Internet-based Self-help Treatment for Panic Disorder: Two Ways of Complementary Psychological Support
NCT02402322 ·Status: COMPLETED ·Phase: NA
-
Neurobiology of Generalized Fear-Conditioning & Avoidance in Anxiety Disorders
NCT03033056 ·Status: COMPLETED
-
Mechanisms of Treatment Change in Panic Disorder and Agoraphobia
NCT03547180 ·Status: COMPLETED ·Phase: NA
-
Clinical Markers of Panic and Generalized Anxiety Disorder
NCT06071819 ·Status: COMPLETED
-
The Association Between Physical Sensations and Thinking Styles
NCT03233542 ·Status: COMPLETED ·Phase: NA
-
Evaluation and Follow-up of Individuals With Obsessive-Compulsive Disorder and Related Conditions
NCT00004550 ·Status: COMPLETED
-
Open/Aftercare Treatment for Participants Diagnosed With Obsessive Compulsive Disorder
NCT03511534 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Improving Quality of Primary Care for Patients With Anxiety and/or Panic Disorders
NCT00102427 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Pilot Study of Pharmaceutical and Behavioral Interventions to Treat Anxiety Disorders
NCT01631682 ·Status: COMPLETED ·Phase: PHASE4
-
Neuroimaging of Pavlovian Fear Conditioning Processes in Patients With Pathological Anxiety
NCT03498599 ·Status: UNKNOWN ·Phase: NA
-
An OCD Prevention Programme for at Risk Adults
NCT06262464 ·Status: RECRUITING ·Phase: NA
-
Optimizing Cognitive-behavioral Therapy for Social Anxiety Disorder Using the Factorial Design
NCT04879641 ·Status: COMPLETED ·Phase: NA
-
A New Intervention to Improve Function in Veterans With Anxiety and Depression
NCT06188923 ·Status: RECRUITING ·Phase: PHASE2
-
Definitive Selection of Neuroimaging Biomarkers in Anxiety Disorder and Obsessive-compulsive Disorder: A Longitudinal Functional Magnetic Resonance Imaging (fMRI) Study With Paroxetine Treatment
NCT03894085 ·Status: COMPLETED ·Phase: NA
-
Dealing With Intrusive Thoughts in OCD - a Comparison of Detached Mindfulness and Cognitive Restructuring
NCT03002753 ·Status: COMPLETED ·Phase: NA
-
Cognitive Behavioural Therapy for Anxiety Disorders in PD
NCT02648737 ·Status: COMPLETED ·Phase: NA
-
Effect of Cognitive-behavior Therapy on Fear Responses to Body Symptoms in Patients With Panic Disorder
NCT04568109 ·Status: COMPLETED ·Phase: NA
-
Study Of Generalized Anxiety Disorder
NCT00135525 ·Status: COMPLETED ·Phase: PHASE2
-
Breathing Regulation Training for Individuals With Panic Disorder
NCT00183521 ·Status: COMPLETED ·Phase: NA
-
Clonazepam and Paroxetine for Rapid Treatment of Post-Traumatic Stress Disorder
NCT00025740 ·Status: COMPLETED ·Phase: PHASE4